Dihydrotestosterone: a rationale for its use as a non-aromatizable androgen replacement therapeutic agent (Q33637784)

28 July 2017

1 reference

title

Dihydrotestosterone: a rationale for its use as a non-aromatizable androgen replacement therapeutic agent (English)

1 reference

28 July 2017

Swerdloff RS

1

1 reference

PubMed ID

10332569

28 July 2017

Wang C

series ordinal

2

1 reference

28 July 2017

1 October 1998

1 reference

Bailliere's clinical endocrinology and metabolism

28 July 2017

1 reference

28 July 2017

12

1 reference

28 July 2017

3

1 reference

28 July 2017

501-506

1 reference

Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980267-X

7 January 2021

Identification of androgen receptors in normal human osteoblast-like cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980267-X

7 January 2021

Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980267-X

7 January 2021

Structure-function relationships of rat androgen--binding protein/human sex-hormone binding globulin: the effect of mutagenesis on steroid-binding parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980267-X

7 January 2021

Transdermal dihydrotestosterone treatment of 'andropause'.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980267-X

7 January 2021

Treatment of persistent pubertal gynecomastia with dihydrotestosterone heptanoate.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980267-X

7 January 2021

Sex hormone-binding globulin/androgen-binding protein: steroid-binding and dimerization domains

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980267-X

7 January 2021

Dihydrotestosterone heptanoate: synthesis, pharmacokinetics, and effects on hypothalamic-pituitary-testicular function

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980267-X

7 January 2021

Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980267-X

7 January 2021

Comparison of spontaneous and experimentally induced canine prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980267-X

7 January 2021

Androgen receptors in osteoblast-like cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980267-X

7 January 2021

Role of 5 alpha-reductase in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980267-X

7 January 2021

Anatomic distribution and regulation of aromatase gene expression in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980267-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980267-X

1 reference

7 January 2021

Different levels of 5alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980267-X

7 January 2021

On the Role of Dihydrotestosterone in Regulating Luteinizing Hormone Secretion in Man*

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980267-X

7 January 2021

Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980267-X

7 January 2021

Different patterns of metabolism determine the relative anabolic activity of 19-norandrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980267-X

7 January 2021

Search for a substance which selectively inhibits FSH--effects of steroids and prostaglandins on serum FSH and LH levels

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980267-X

7 January 2021

Long-term transdermal dihydrotestosterone therapy: effects on pituitary gonadal axis and plasma lipoproteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980267-X

7 January 2021

The induction of prostatic hypertrophy in the dog with androstanediol

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980267-X

7 January 2021

Comparative pharmacokinetics of three doses of percutaneous dihydrotestosterone gel in healthy elderly men--a clinical research center study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980267-X

7 January 2021

Possible mechanism of induction of benign prostatic hyperplasia by estradiol and dihydrotestosterone in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980267-X

7 January 2021

Induction of benign prostatic hyperplasia in intact dogs by near-physiological levels of 5 alpha-dihydrotestosterone and 17 beta-estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980267-X

7 January 2021

Human prostatic smooth muscle cells in culture: estradiol enhances expression of smooth muscle cell-specific markers.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980267-X

7 January 2021

10.1016/S0950-351X(98)80267-X

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10332569